cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 1.6% – Here’s What Happened

cbdMD, Inc. (NYSEAMERICAN:YCBD) traded down 1.6% during mid-day trading on Thursday. The company traded as low as $0.3622 and last traded at $0.3728. 74,629 shares changed hands during trading, a decline of 16% from the average daily volume of 89,154 shares. The stock had previously closed at $0.3789.

Analyst Ratings Changes

Separately, Maxim Group lowered shares of cbdMD from a “buy” rating to a “hold” rating in a report on Monday, August 17th. One research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, cbdMD has an average rating of “Hold”.

cbdMD Price Performance

The firm’s 50-day simple moving average is $0.45 and its two-hundred day simple moving average is $0.62.

cbdMD (NYSEAMERICAN:YCBD) last announced its earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.08). cbdMD had a negative return on equity of 34.26% and a negative net margin of 13.80%. The company had revenue of $5.55 million for the quarter, compared to analyst estimates of $5.69 million.

About cbdMD

cbdMD, Inc (NYSE American: YCBD) is a consumer health and wellness company that develops, markets and sells hemp-derived cannabinoid products. Its offerings have included cannabidiol (CBD) oils and tinctures, gummies and other ingestible products, capsules, creams and lotions, as well as products formulated for sleep, recovery and general wellness.

The company also markets CBD products for pets and has expanded its portfolio to include additional cannabinoid-based and functional wellness products.